참고문헌
- Calfano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman,G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W. and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56: 2488-2492
- Slaughter, D.L., Southwick, H.W., Smejkal, W. Filed cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6: 963-968 https://doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q
- Patridge, M., Emilion, G., Pateromichelakis, S., Phillips, E., and Langdon, J. Field cancerisation of the oral cavity: comparison of the spectrum of molecular alrerations in cases presention with both dysplastic and malignant lesions. Oral. Oncel. 1997;33: 332-337 https://doi.org/10.1016/S1368-8375(97)00035-3
- Shklar, G. Development of experimental oral carcinogenesis and its impact on current oral cancer research. J. Dent. Res. 1999;78: 1768-1772 https://doi.org/10.1177/00220345990780120101
- Eveson, J.W. Animal models of intra-oral chemical carcinogenesis: a review. J. Oral. Pathol. 1981;10: 129-146 https://doi.org/10.1111/j.1600-0714.1981.tb01259.x
- Fisker, A.V. Experimental oral carcinogenesis. A basic rat model for the study of oral carcinogenesis using the carcinogen 4-nitroquinoline 1-oxide. Dan. Med. Bull. 1990;15:43-47
- Steidler, N.E., and Reade, P.C. Initiation and promotion of experimental oral mucosal carcinogenesis in mice. J. Oral. Pathol. 1986;15: 43-47 https://doi.org/10.1111/j.1600-0714.1986.tb00562.x
- Tanaka, T., Kawamori, T., Ohnishi, M., Okamoto, K., Mori, H. and Hara, A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res. 1994;54: 2359-2365
- Ohne, M., Satoh, T., Yamada, S. and Takai, H. Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4-NQO) in drinking water. Oral Surg. Oral Med. Oral Pathol. 1985;59: 600-607 https://doi.org/10.1016/0030-4220(85)90189-6
- Wallenius, K. and Lekholm, U. Oral cancer in rats induced by the water soluble carcinogen 4-nitroquinoline 1-oxide. Odont. Rev. 1973;24: 39-48
- Moore, M.A. and Tsuda, H. Chronically elevated proliferation as a risk factor for neoplasia. Eur. J. Cancer Prev. 1998;7: 353-385 https://doi.org/10.1097/00008469-199810000-00002
- Mori, H., Sugie, S., Yoshimi, N., Hara, A. and Tanaka, T. control of cell proliferation in cancer prevention. Mutat Res. 1999;428: 291-298 https://doi.org/10.1016/S1383-5742(99)00055-1
- Sharma, R.A., Manson, M.M., Gescher, A. and Steward, W.P. Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents. Eur. J. Cancer. 2001;37: 12-22
- Adams, J.M., Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281: 1322-1326 https://doi.org/10.1126/science.281.5381.1322
- Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., Macgregor, G.R., Thompson, C.B., and Korsmeyer, S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 1998;292: 727-730
- Zong, W.X.,, Lindsten, T., Ross, A.J., MacGregor. G.R., Thompson, C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 2001;15: 1481-1486 https://doi.org/10.1101/gad.897601
- Antonsson, B., Montessuit, S., Lauper, S., Eskes, R., Martinou, J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J. 2000 ;345 Pt 2: 271-278 https://doi.org/10.1042/0264-6021:3450271
- Jurgensmeier, J.M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D., Reed, J.C. Bax directly induces release of cytochrome c from isolated mitochondria.Proc Natl Acad Sci U S A. 1998;95: 4997-5002
- Wei, M.C., Lindsten, T., Mootha, V.K., et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 2000;14: 2060-71
- Reed, J.C. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124: 1-6 https://doi.org/10.1083/jcb.124.1.1
- Reed, J.C., Miyashita, T., Takayama, S., et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy.J Cell Biol. 1996;60: 23-32
- Ziwei, H. Bcl-2 proteins as target for anticancer durg design. Oncogene. 2000;19: 6627-6631 https://doi.org/10.1038/sj.onc.1204087
- Mikhailov, V., Mikhailova, M., Pulkrabek, D.J., Dong, Z., Venkatachalam, M.A., Saikumar, P. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem. 2001;276:18361-18374 https://doi.org/10.1074/jbc.M100655200
- Murphy, K.M., Streips, U.N., Lock, R.B. Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation. J Biol Chem. 2000;275:17225-17228 https://doi.org/10.1074/jbc.C900590199
- Akao, Y., Otsuki, Y., Kataoka, S., Ito, Y., Tsujimoto, Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 1994;54: 2468-2471
- Foyouzi-Youssefi, R., Arnaudeau, S., Borner, C., et al. Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A. 2000;97: 5723-5728
- He, H., Lam, M., McCormick, T.S., Distelhorst, C.W. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol. 1997;138: 1219-28 https://doi.org/10.1083/jcb.138.6.1219
- Lam, M., Dubyak, G., Chen, L., Nunez, G., Miesfeld, R.L., Distelhorst, C.W.. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci U S A. 1994;91: 6569-6573
- Nutt, L.K., Pataer, A., Pahler, J., et al. Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem. 2002;277: 9219-9225 https://doi.org/10.1074/jbc.M106817200
- Pinton, P., Ferrari, D., Magalhaes, P., et al. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J Cell Biol. 2000;148: 857-862 https://doi.org/10.1083/jcb.148.5.857
- Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993 ;74: 609-19 https://doi.org/10.1016/0092-8674(93)90509-O
- Oltvai, Z.N., Korsmeyer, S.J. Checkpoints of dueling dimers foil death wishes. Cell. 1994 ;79: 189-92 https://doi.org/10.1016/0092-8674(94)90188-0
- John, CR. Bcl-2 family proteins. Oncogene. 1998;17: 3225-3236 https://doi.org/10.1038/sj.onc.1202591
- Hsu, S.Y., Hsueh, A.J. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro. J Biol Chem. 1998;273: 30139-30146 https://doi.org/10.1074/jbc.273.46.30139
- Show, M.D., Folmer, J.S., Anway, M.D., Zirkin, B.R. Testicular expression and distribution of the rat bcl2 modifying factor in response to reduced intratesticular testosterone. Biol Reprod. 2004;70: 1153-1161 https://doi.org/10.1095/biolreprod.103.023200
- Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W., Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 2001;7: 673-682 https://doi.org/10.1016/S1097-2765(01)00213-1
- Nakano, K., Vousden,K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 2001; 7: 683-694 https://doi.org/10.1016/S1097-2765(01)00214-3
- Reed JC. Mechanisms of apoptosis avoidance in cacner. Curr Opin Oncol 1999; 11:68-75 https://doi.org/10.1097/00001622-199901000-00014
- Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Ivestigation of environmental factors for diagnosting malignant potential in oral epithelial dysplasia
- Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68: 251-306 https://doi.org/10.1016/S0074-7696(08)62312-8
- Ravi D, Nalinakumari KR, Rajaram RS, Nair MK, Pillai MR. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett. 1996;105(2):139-46 https://doi.org/10.1016/0304-3835(96)04258-9
- Jordan RC, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol. 1996;32(6):394-400 https://doi.org/10.1016/S0964-1955(96)00033-4
- Koide N, Koike S, Adachi W, Amano J, Usuda N, Nagata T. Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus. Surg Today. 1997;27(8):685-91 https://doi.org/10.1007/BF02384977
- Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol. 1998;29(2):146-54 https://doi.org/10.1016/S0046-8177(98)90225-8
- Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. 1994 ;145(6):1323-36
- Chrysomali E, Greenspan JS, Dekker N, Greenspan D, Regezi JA. Apoptosis-associated proteins in oral hairy leukoplakia. Oral Dis. 1996 ;2(4):279-84 https://doi.org/10.1111/j.1601-0825.1996.tb00238.x
- Loro LL, Vintermyr OK, Liavaag PG, Jonsson R, Johnnessen AC. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and incresed apoptosis. Hum Pathol ;30:1097-1105 https://doi.org/10.1016/S0046-8177(99)90229-0
- O'Reilly L. A., Print C., Hausmann G., et al. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death Differ., 2001;8:486-494 https://doi.org/10.1038/sj.cdd.4400835
- Wilson JW, Nostro MC, Balzi M, et al. Bcl-w expression in colorectal adenocarcinoma. Br J Cancer. 2000;82(1):178-85 https://doi.org/10.1054/bjoc.1999.0897
- Lee HW, Lee SS, Lee SJ, Um HD. Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation. Cancer Res. 2003;63(5):1093-100
- Li D, Ueta E, Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. 2004;95(8):644-50 https://doi.org/10.1111/j.1349-7006.2004.tb03323.x
- Masuda M, Suzui M, Lim JT, Weinstein IB Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res. 2003;9(9):3486-91
- Itoh M, Noutomi T, Chiba H, Mizuguchi J. BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin. Oral Oncol. 2002 ;38(8):752-6 https://doi.org/10.1016/S1368-8375(02)00047-7
- Mihara M, Shintani S, Kiyota A, Matsumura T, Wong DT. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells. Int J Oncol. 2002 ;21(1):95-101
- M.C. Kiefer, M.J. Brauer, V.C. Powers et al., Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 2002 ;374: 736 - 739 https://doi.org/10.1038/374736a0
- S. Krajewski, M. Krajewska and J.C. Reed, Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Research 1996; 56(12): 2849-2855
- M. Krajewska, S.F. Moss, S. Krajewski, K Song, P.R. Holt and J.C. Reed, Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Research 1996; 56(10) : 2422–2427
- M. Krajewska, C.M. Fenoglio-Preiser, S. Krajewski et al., Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. American Journal of Pathology 1996; 149(5): 1449-1457
- Xie X, Clausen OP, Boysen M. Prognostic value of Bak expression in oral tongue squamous cell carcinomas. Oncol Rep. 2003 ;10(2):369-74
- Huang DC, Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell. 2000;103(6):839-42 https://doi.org/10.1016/S0092-8674(00)00187-2
- Ferrer A, Marce S, Bellosillo B, et al. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene. 2004; 23(55) : 8941-9. https://doi.org/10.1038/sj.onc.1208084
- Nakano K, Vousden KH. PUMA, a novel porapoptotic gene, is induced by p53. Molecular Cell 2001;7: 683-694 https://doi.org/10.1016/S1097-2765(01)00214-3
- Han J, Flemington C, Houghton AB, et al. Expression of bbc3, a pro-apoptotoic Bch3-only gene, is regulated by diverse cell death and survival signals. Proceedings of the National Academy of Sciences of the USA. 2001;98:11318-11323